

Doximity GPT launched in 2023 as a HIPAA-compliant assistant for clinicians. In 2025 it became Doximity Ask. Same product, new name, and a much bigger evidence base after Doximity bought the clinical reference company Pathway.
Ask answers clinical questions with citations, writes appeal letters and patient handouts, and looks up drugs. It is free for verified US physicians, nurse practitioners, physician assistants and medical students. This review covers what changed, what it does, and where the edges are.
Type a clinical question and Ask answers with inline citations. Click a citation and you land on the source. Doximity says the library covers guidelines, studies and full-text PDFs from more than 2,000 peer-reviewed journals. No extra login, no paywall.
Drug questions get special treatment. Start typing a drug name and Instant Answers appear from a set of more than 3,200 drug monographs. These are peer-reviewed entries, not generated text. Dosing, interactions, side effects and prescribing details come from FDA labelling and clinical references.
Answers are checked by people. Through a program called PeerCheck, more than 12,000 physicians review and improve AI answers on an ongoing basis. For hard cases there is a Thinking Mode that takes longer and reasons through more variables.
The writing side is what made Doximity GPT popular in the first place. Ask drafts insurance appeals, prior authorisation letters, patient education at a chosen reading level, translations and chart note templates. You can upload labs, notes or a PDF and ask questions about the file. Projects save your templates and preferences for recurring tasks.
Finished text can go straight out. Share by secure text or fax from inside Ask. Or copy it in an EMR-friendly format for pasting into the chart.
3 Views
Nothing for individuals. Ask is free for every user with a verified Doximity account. The same goes for Doximity Scribe and the basic Dialer plan. Hospitals and health systems can buy enterprise licences, priced on request.
Doximity itself is a listed company. It earns from its network, mostly marketing to clinicians on behalf of drug companies and health systems, and from recruiting. Ask carries no fee and shows no ads inside answers.
Verified US clinicians. Doximity checks credentials before it opens a profile. Physicians, nurse practitioners, physician assistants, pharmacists, dentists, podiatrists and medical students all qualify. Doximity says more than 85 percent of US physicians are members.
If you are not a US clinician, there is no way in. There is no patient version and no public tier.
Not by itself. The scribe is a separate free tool called Doximity Scribe. It listens to the visit, works from SOAP, H&P and consult templates or your own, and takes dictation. It lives in the same app as Ask and Dialer.
Ask and Scribe are not one product. Ask is not embedded in the Dialer call screen either. Doximity's own help pages suggest keeping Ask open in a second tab during a call. If you want notes and evidence in one flow, that is a gap.
The name keeps moving. Searches, the support URL and older blog posts still say Doximity GPT or DoxGPT. New users have to work out that Ask is the same thing.
It only comes as part of Doximity. You join a professional network to use it, with everything that brings. There is no standalone sign-up.
Calculators are web only. The mobile app has Drug Look Up and CME but not the score calculators.
The tools sit side by side rather than together. Ask, Scribe and Dialer share an app but not a single workflow.
US only. Verification, drug labelling and the CME credit are all built for American practice.
Yes, for any US clinician who already has a Doximity profile. Most do. The price is zero and the drug reference alone is worth the tap.
Judge it against OpenEvidence, the other free clinical AI. OpenEvidence has the journal partnerships. Ask has the drug data, the letter writing, and fax and text built in. Many clinicians will end up with both on the phone. It costs nothing to find out which one you reach for.